All Eyes On Pricing Model As EU Crunch Time Nears For First Ophthalmic Bevacizumab

 
• By Neena Brizmohun
  
EU flag reflected in eye
EMA to decide on EU marketing application for wet AMD drug Lytenava • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography